Nuformix Plc (GB:NFX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nuformix Plc confirms its total voting rights, following the issuance of new shares, with a total of 1,419,309,368 ordinary shares in circulation, each holding one vote. This information is crucial for shareholders to calculate their notification requirements under FCA rules. Nuformix, a pharmaceutical company focusing on fibrosis and oncology, aims to innovate through drug repurposing, offering new commercial opportunities.
For further insights into GB:NFX stock, check out TipRanks’ Stock Analysis page.